STRUUTHE Trademark

Trademark Overview


On Tuesday, November 5, 2019, a trademark application was filed for STRUUTHE with the United States Patent and Trademark Office. The USPTO has given the STRUUTHE trademark a serial number of 88680936. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by Eli Lilly and Company. The STRUUTHE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
struuthe

General Information


Serial Number88680936
Word MarkSTRUUTHE
Filing DateTuesday, November 5, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2022SOU EXTENSION 5 GRANTED
Friday, September 23, 2022SOU EXTENSION 5 FILED
Friday, September 23, 2022TEAS EXTENSION RECEIVED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 22, 2022SOU EXTENSION 4 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 4 FILED
Wednesday, March 16, 2022TEAS EXTENSION RECEIVED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 3 GRANTED
Wednesday, August 18, 2021SOU EXTENSION 3 FILED
Wednesday, August 18, 2021TEAS EXTENSION RECEIVED
Friday, April 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 31, 2021SOU EXTENSION 2 GRANTED
Wednesday, March 31, 2021SOU EXTENSION 2 FILED
Wednesday, March 31, 2021TEAS EXTENSION RECEIVED
Wednesday, September 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 22, 2020SOU EXTENSION 1 FILED
Tuesday, September 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 22, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 16, 2020ASSIGNED TO EXAMINER
Wednesday, November 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2019NEW APPLICATION ENTERED